Trial record 1 of 2 for:    fkd
Previous Study | Return to List | Next Study

Intravesical Administration of INSTILADRIN (rAd-IFN With Syn3) in Patients With Bladder Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
FKD Therapies Oy
ClinicalTrials.gov Identifier:
NCT01687244
First received: September 6, 2012
Last updated: February 6, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)